Ligand Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

22.01.18	Ligand Enters into Worldwide OmniAb® Platform License Agreement with Ferring Pharmaceuticals (Businesswire)
18.01.18	Ligand Establishes Program to Develop Captisol-Enabled, Next-Generation Contrast Agents for Diagnostic Imaging (Businesswire)
11.01.18	Ligand Enters into Worldwide OmniAb® Platform License Agreement with Glenmark Pharmaceuticals (Businesswire)
03.01.18	Ligand Earns $6 Million as OmniAb Partner Out-Licenses Antibody Projects (Businesswire)
14.11.17	Ligand Provides Highlights from Today’s Analyst Day Event (Businesswire)
09.11.17	Ligand Reports Third Quarter 2017 Financial Results (Businesswire)
06.11.17	Reminder: Ligand to Host Analyst Day on November 14th in New York City (Businesswire)
02.11.17	Ligand to Participate in the Stephens Fall Investment Conference (Businesswire)
24.10.17	Ligand to Report Third Quarter 2017 Results on November 9th (Businesswire)
03.05.17	Zika Care Connect website offers families access to medical specialists (PR Newswire)
07.04.17	Muskingum University Installs Dr. Susan S. Hasseler As Its 21st President (PR Newswire)
18.01.17	Lemelson Capital Management Announces 2016 Performance Results for The Amvona Fund, LP (PR Newswire)
22.12.16	Ligand In License And Supply Deals With Novartis For Captisol-enabled Trametinib (RTTNews)
21.12.16	Lantern Foundation Founder Urges Senate Committee to Commence Investigation into Ligand Pharmaceuticals (PR Newswire)
22.11.16	LGND LOSS ALERT: Rosen Law Firm Reminds Ligand Pharmaceuticals Incorporated Investors of Important Deadline in Class Action Filed by Firm- LGND (PR Newswire)
03.11.16	Ligand Pharmaceuticals Inc Reveals 12% Gain In Q3 Earnings (RTTNews)
25.10.16	INO Slips On Clinical Hold, MRK Gets FDA Nod, Be All Ears For AKAO (RTTNews)
13.09.16	Ligand Pharma Initiates Phase 2 Trial For LGD-6972 - Quick Facts (RTTNews)
07.09.16	Retrophin Reports Positive Top-line Results From Sparsentan Phase 2 DUET Study (RTTNews)
04.08.16	Ligand Pharmaceuticals Inc Earnings Fall 72% In Q2 (RTTNews)
04.05.16	Ligand Pharma Q1 Tops View, Ups Forecast; To Buy Economic Rights From CorMatrix (RTTNews)
04.05.16	Ligand Pharmaceuticals Inc Q1 Income Rises 205% (RTTNews)
22.04.16	Ligand Announces First Quarter 2016 Earnings Reporting Date and Participation in Four Upcoming Investor Conferences (Businesswire)
20.04.16	Spectrum Pharma Receives FDA Orphan Drug Exclusivity For EVOMELA - Quick Facts (RTTNews)
07.04.16	Revolade® Approved in EU as First in Class Therapy for Children Aged 1 Year and Above with Chronic ITP (Businesswire)
28.03.16	Ligand Enters Into OmniAb® Platform License Agreement With ABBA Therapeutics (Businesswire)
15.03.16	Spectrum Pharma: EVOMELA Receives FDA Approval For Two Indications - Quick Facts (RTTNews)
10.02.16	Ligand Pharma Raises 2016 Guidance (RTTNews)
10.02.16	Ligand Pharmaceuticals Inc Reveals 14% Gain In Q4 Profit (RTTNews)
09.11.15	Ligand Pharmaceuticals Inc Reports 57% Increase In Q3 Earnings (RTTNews)
23.10.15	Spectrum Pharma Receives FDA Response Letter For EVOMELA - Quick Facts (RTTNews)
02.09.15	Revolade® Receives EU Approval as First-in-Class Therapy for Patients with Severe Aplastic Anemia (Businesswire)
04.08.15	Ligand Profit Surges, Reaffirms FY Guidance; Appoints Matthew Korenberg CFO (RTTNews)
04.08.15	EARNINGS SUMMARY: Ligand Pharmaceuticals Inc Income Rises (RTTNews)
24.07.15	Ligand Pharma: Revolade Recommended By CHMP For EU Approval To Treat SAA (RTTNews)
24.07.15	Revolade® Recommended by CHMP for EU Approval to Treat Patients with Severe Aplastic Anemia, a Serious Blood Disorder (Businesswire)
15.06.15	CRBP Is One To Keep An Eye On, FDA Expands Use Of Promacta, OSUR Gets Funds (RTTNews)
11.05.15	Ligand Acquires Rights to More Than 15 Fully-Funded Development Programs from Selexis SA (Businesswire)
05.05.15	Ligand Pharma Partner Viking Therapeutics Closes IPO Of 3 Mln Shares (RTTNews)
09.02.15	Ligand Pharma Q4 Profit Rises - Quick Facts (RTTNews)
09.02.15	Ritter Pharma Appoints Matthew Foehr To Board - Quick Facts (RTTNews)
04.02.15	AMGN's Biosimilar Matches Blockbuster, PFE Gets FDA Nod, LGND Does A Deal (RTTNews)
03.02.15	Ligand Pharma Inks License Deal With Sermonix For Lasofoxifene - Quick Facts (RTTNews)
03.02.15	Ligand Promotes Matthew Foehr To President (RTTNews)
09.01.15	Ligand Pharma Partner Retrophin Gets Orphan Drug Designation For Sparsentan (RTTNews)
26.12.14	Spectrum Pharma Submits NDA For CE-Melphalan - Quick Facts (RTTNews)
19.12.14	Ligand Partner Pfizer Receives European Marketing Authorization for DUAVIVE® (Conjugated Estrogens/Bazedoxifene) for Treatment of Estrogen Deficiency Symptoms in Postmenopausal Women with a Uterus (Businesswire)
12.11.14	GSK Reports EU Submission For Severe Aplastic Anemia Indication For Revolade (RTTNews)
12.11.14	Ligand Partner GlaxoSmithKline Announces EU Regulatory Submission for Severe Aplastic Anemia Indication for Revolade™ (eltrombopag) (Businesswire)
27.10.14	Ligand Pharma Q3 Profit Down; Reiterates Annual Guidance (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’280.50	1.07 %	K V
Kuehne+Nagel Int	203.50	0.44 %	K V
Alcon	76.52	0.26 %	K V
Holcim	89.00	0.16 %	K V
Logitech Intl	74.90	0.05 %	K V
Swisscom	502.00	-0.99 %	K V
Sika	223.80	-1.06 %	K V
Swiss Re	129.80	-1.63 %	K V
Givaudan	3’983.00	-1.92 %	K V
Nestle	73.70	-2.02 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Ligand Pharmaceuticals Inc

Aktien Top/Flop

Meistgelesene Nachrichten